Understanding Low Life Essential 8 Scores: A Critical Risk Factor for Long-Term Mortality

Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a major health issue characterized by ongoing airflow limitations. Common symptoms include shortness of breath, coughing, and sputum production. COPD is the third leading cause of death globally, with increasing incidence and mortality rates each year. A 2019 CDC analysis highlighted that in 2017, COPD was the fourth leading cause of years of life lost in China. The annual direct medical costs for COPD patients in China range from $72 to $3,565, which can be 33.33% to 118.09% of average yearly income in those regions. COPD significantly affects patients’ quality of life and burdens overall health.

This study aims to analyze the connection between LE8 scores and mortality from cardiovascular disease, chronic lower respiratory disease, and cancer in patients with COPD to improve survival rates.

Materials and Methods

Study Design and Population

This study used data from the National Health and Nutrition Examination Survey (NHANES) from 2007 to 2012. NHANES collects health, nutrition, and demographic data from a representative sample of the U.S. population. The analysis included mortality data from the National Death Index (NDI) up to December 31, 2019. Participants under 20, without COPD, lacking LE8 scores, or death status were excluded, resulting in a final cohort of 785 adults.

Definitions of LE8 Metrics

LE8 metrics were measured through two dietary surveys: the Dietary Approaches to Stop Hypertension (DASH) and the Mediterranean Eating Pattern for Americans (MEPA). A score of 100 points was assigned for optimal dietary patterns. Physical activity levels, nicotine exposure from smoking, sleep duration, Body Mass Index (BMI), cholesterol levels, blood pressure, and blood glucose were all incorporated into the LE8 scoring system. The overall LE8 score was classified into three categories: low cardiovascular health (CVH) (0–420), moderate CVH (421–530), and high CVH (531–780).

COPD Diagnostic Criteria

COPD diagnosis relied on the following criteria:

1. FEV1/FVC <70% post-bronchodilator.
2. Prior diagnosis of emphysema.
3. Age above 40 with a history of smoking, chronic bronchitis, or specific medication use.

Assessment of Outcomes and Covariates

The study included variables such as age, gender, race/ethnicity, education, poverty incidence, cardiovascular disease history, and alcohol use. Race categories included non-Hispanic White, non-Hispanic Black, Hispanic, and others. Educational attainment was classified as bachelor’s degree or higher, high school diploma, or less than one year of education. The poverty incidence ratio (PIR) was measured, and a history of cardiovascular disease was documented.

Statistical Analysis

Statistical analyses employed R software for data evaluation. Continuous variables were summarized as means, while categorical variables were presented as counts and percentages. Differences across groups were analyzed using ANOVA and chi-square tests. Weighted Cox proportional hazards regression examined the relationship between LE8 scores and mortality, with adjustments across models. The Kaplan-Meier survival curve illustrated all-cause mortality based on LE8 groupings.

Results

Characteristics of the Participants

The analysis involved 785 individuals with COPD, averaging 59 years in age. Among participants, 58.37% were male. Education levels varied, with 54.4% having completed college, and smoking status revealed 44% were trying to quit, while 35.6% were current smokers. Alcohol consumption showed that 65.6% were current drinkers. Health conditions included 53.8% with hypertension and 83.9% with hyperlipidemia.

Individuals in the high LE8 group showed better economic and education levels, higher FEV1/FVC ratios, and lower rates of hyperlipidemia and cardiovascular disease.

COPD Survivors and Non-Survivors

Among participants, 245 deaths occurred, with an average age of 67. Significant differences in demographics and clinical characteristics were found between survivors and non-survivors. A notable correlation was observed between hypertension prevalence and mortality.

LE8 and Mortality Correlation

Table 4 outlines hazard ratios (HR) for LE8 scores related to all-cause mortality. Higher LE8 scores correlated with reduced mortality risk. The analysis indicated that individuals with higher LE8 scores had significantly better survival rates compared to those with lower scores.

Discussion

This research is the first to explore the relationship between LE8 scores and mortality in COPD patients. A high LE8 score indicates a 60% lower risk of death from all causes. Increased LE8 scores also linked to reduced risks of mortality from respiratory disease and cardiovascular issues.

Limitations include a reduced sample size due to missing spirometry and LE8 measurements. Self-reporting may introduce measurement errors. Future research should include longitudinal studies to further understand the relationship between LE8 and COPD mortality.

Conclusion

The LE8 framework provides a comprehensive measure for evaluating cardiovascular health in COPD patients. Higher LE8 scores suggest improved survival and reduced mortality risks, emphasizing the importance of lifestyle factors in COPD management.